Alnylam Pharmaceuticals, Inc.

CULLEN/FROST BANKERS, INC. ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/6/2026

Shares

11,033

Value ($000)

4,387

Weight

0.0%

2020 Q1 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/6/2026	4,387	0.0%	11,033	12/31/2025
2025 Q3	10/31/2025	5,036	0.1%	11,043	9/30/2025
2025 Q2	7/30/2025	3,520	0.0%	10,795	6/30/2025
2025 Q1	5/2/2025	2,894	0.0%	10,717	3/31/2025
2024 Q4	2/6/2025	2,503	0.0%	10,639	12/31/2024
2024 Q3	11/6/2024	2,925	0.0%	10,635	9/30/2024
2024 Q2	8/5/2024	2,565	0.0%	10,555	6/30/2024
2024 Q1	5/10/2024	1,578	0.0%	10,562	3/31/2024
2023 Q4	2/6/2024	2,019	0.0%	10,549	12/31/2023
2023 Q3	11/2/2023	1,868	0.0%	10,549	9/30/2023
2023 Q2	8/4/2023	2,004	0.0%	10,549	6/30/2023
2023 Q1	5/5/2023	2,113	0.0%	10,549	3/31/2023
2022 Q4	2/13/2023	2,507	0.0%	10,549	12/31/2022
2022 Q3	11/7/2022	2,111	0.0%	10,549	9/30/2022
2022 Q2	8/5/2022	1,597	0.0%	10,949	6/30/2022
2022 Q1	5/9/2022	1,788	0.0%	10,949	3/31/2022
2021 Q4	2/7/2022	1,789	0.0%	10,549	12/31/2021
2021 Q3	11/4/2021	1,992	0.0%	10,549	9/30/2021
2021 Q2	8/5/2021	1,788	0.0%	10,549	6/30/2021
2021 Q1	5/5/2021	1,655	0.0%	11,725	3/31/2021
2020 Q4	2/8/2021	1,524	0.0%	11,725	12/31/2020
2020 Q3	11/5/2020	2,913	0.1%	20,009	9/30/2020
2020 Q2	8/5/2020	3,088	0.1%	20,849	6/30/2020
2020 Q1	5/1/2020	2,452	0.1%	22,523	3/31/2020